| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_734d1284b617dcf41645d82bb763ad5a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
1999-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b805489585b69e9bff1e33a1ccbba7c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d371f48863d88ed55bd99ee30cc5634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e032be37482cd11e6a2f683acd021a |
| publicationDate |
2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2000325100-A |
| titleOfInvention |
Screening method for TCP-1 containing chaperonin expression regulator |
| abstract |
PROBLEM TO BE SOLVED: To provide a screening method for an expression controlling substance such as a CCT expression inhibitor and an expression inducing agent for finding a substance which specifically regulates the expression of a TCP-1 containing chaperonin (CCT). C that can be selected by the screening method To provide a CT expression inhibitor and a pharmaceutical composition containing the CCT expression inhibitor. A CCT expression controlling substance comprising a step of examining the expression of a reporter gene product in the presence of a test compound using a cell line transformed with a vector in which a reporter gene is linked downstream of a CCT gene promoter. And a pharmaceutical composition for treating cancer, comprising a CCT expression inhibitor that can be selected by the screening method, and a CCT expression inhibitor as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02064165-A1 |
| priorityDate |
1999-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |